We Serve

DeciBio Culture

Discover how our data-driven solutions have helped stakeholders in Precision Medicine drive growth and stay ahead of the curve

What we do

Select Capabilities

All Capabilities

Go-to-Market Strategy

It’s time to execute. Understanding your customers, competitors, channels, and messaging is just the first step. Going to market requires coordination and alignment across the organization, and an ivory-tower strategy won’t be enough - you need tactics.

Voice-of-Customer Research

Unbiased. Unfiltered. If you want to know what your current or potential customers think, and what motivates their behavior, then you’ve come to right place. No one gets more comprehensive and nuanced information from real-world life science stakeholders than we do. Period.

Market Landscaping and Sizing

A winning strategy requires deep understanding of the size, growth, segmentation, competitive dynamics, and voice-of-customer in your markets. DeciBio has the qualitative and quantitative research and analysis capabilities to give you the insights you need.

Impact

Selected Work

No items found.

Featured Team

No items found.

Data & Platforms

Europe Oncology Genomics Tracker

This report provides a summary of oncology genomics testing practices, oncologist perspectives and experiences with test providers, and expected future utilization behaviors in Europe. A subscription to this report includes 2 waves of data, collected biannually.

Blood-Based Testing in Neurodegenerative Diseases Competitive Intelligence Report

Blood-based biomarkers are emerging in neurodegenerative disease testing, enabling earlier, less invasive detection and monitoring. This analysis maps activity across clinical trials, publications, pharma pipelines, and routine clinical use to benchmark key biomarkers, disease focus areas, and leading industry players driving this shift.

Pharma Real-Word Data & Evidence Market Report, First Edition: 2025-2030

The first edition of this report provides a comprehensive overview of the global real-world data and evidence (RWD/E) market from 2025 to 2030. RWD has become increasingly central in life sciences decision-making, empowering organizations to generate insights that enhance research, clinical development, and commercial decision-making. The market is expanding as data types diversify, spanning electronic health records, claims, imaging, and omics, and as analytics become more advanced through AI and federated data approaches. Key players include data aggregators, generators (e.g., Guardant Health, Natera), enablers (e.g., COTA, Aetion), as well as players that span multiple functions (e.g., Tempus, Flatiron, NashBio).

Global In Vitro Diagnostics Market Report, First Edition: 2025-2030

DeciBio’s Global In Vitro Diagnostics Market Report, First Edition: 2025-2030, is an in-depth, data-driven resource designed to support strategic decision-making in the IVD space. This report provides a summary of the current IVD landscape, as well as a forward-looking perspective of the IVD market from 2025 to 2030. Content includes a rigorous assessment of industry market size, growth and key trends. In addition, we provide detailed segmentation by modality, therapeutic area, and geography.

Insights Blog

Precision Medicine is evolving at a rapid pace

Discover how we can help